Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

April 01, 1985; Volume 27,Issue 4
  • You have access
    Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor of PC12 cells.
    D Robinson and R McGee
    Molecular Pharmacology April 1985, 27 (4) 409-417;
  • You have access
    Bisquaternary pyridinium oximes as allosteric inhibitors of rat brain muscarinic receptors.
    Y Kloog and M Sokolovsky
    Molecular Pharmacology April 1985, 27 (4) 418-428;
  • You have access
    Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.
    A C Howlett
    Molecular Pharmacology April 1985, 27 (4) 429-436;
  • You have access
    Butyrylcholinesterase: inhibition by arsenite, fluoride, and other ligands, cooperativity in binding.
    J D Page, I B Wilson and I Silman
    Molecular Pharmacology April 1985, 27 (4) 437-443;
  • You have access
    Interaction of phenylglyoxal with the human erythrocyte (Ca2+ + Mg2+)-ATPase. Evidence for the presence of an essential arginyl residue.
    B U Raess, D M Record and G Tunnicliff
    Molecular Pharmacology April 1985, 27 (4) 444-450;
  • You have access
    Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide.
    W Lilienblum, B S Bock-Hennig and K W Bock
    Molecular Pharmacology April 1985, 27 (4) 451-458;
  • You have access
    Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
    G S Marks, D T Allen, C T Johnston, E P Sutherland, K Nakatsu and R A Whitney
    Molecular Pharmacology April 1985, 27 (4) 459-465;
  • You have access
    Potential energy functions and the role of the conformational entropy of clonidine-like imidazolidines in determining their affinity for alpha-adrenergic receptors.
    F Avbelj and D Hadzi
    Molecular Pharmacology April 1985, 27 (4) 466-470;
  • You have access
    Sexual differentiation of cytochrome P-450 in rat liver. Evidence for a constitutive isozyme as the male-specific 16 alpha-hydroxylase.
    E T Morgan, C MacGeoch and J A Gustafsson
    Molecular Pharmacology April 1985, 27 (4) 471-479;
  • You have access
    Interaction of DNA-intercalating antitumor agents with adrenoceptors.
    A Adams, B Jarrott, B C Elmes, W A Denny and L P Wakelin
    Molecular Pharmacology April 1985, 27 (4) 480-491;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 27, Issue 4
1 Apr 1985
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics